Table 2

Cardiometabolic risk factors in young, normal-weight Japanese women with low, normal and high percentage body fat

Percentage body fat*
LowNormalHigh
n=67n=160n=24
Fasting glucose (mg/dL)82 ± 783 ± 783 ± 5
HbA1c (%)5.2 ± 0.25.2 ± 0.25.1 ± 0.3
FFA (mEq/L)0.55 ± 0.170.57 ± 0.240.5 ± 0.21
Fasting insulin (μU/mL)5.3 ± 2.56.3 ± 3.66.6 ± 3.5
HOMA-IR1.1 ± 0.61.3 ± 0.81.3 ± 0.8
AT-IR2.9 ± 1.93.7 ± 3.32.7 ± 1.5
Triglyceride (mg/dL)52 ± 2357 ± 2565 ± 32
Cholesterol (mg/dL)177 ± 25182 ± 26199 ± 28†‡
HDL cholesterol (mg/dL)76 ± 1275 ± 1470 ± 15†‡
LDL cholesterol (mg/dL)91 ± 2096 ± 21117 ± 30†‡
Apolipoprotein A1 (mg/dL)165 ± 18165 ± 20154 ± 20†‡
Apolipoprotein B (mg/dL)66 ± 1270 ± 1484 ± 19†‡
Leptin (ng/mL)5.8 ± 1.79.1 ± 313.2 ± 5§†‡
Adiponectin (µg/mL)11.6 ± 3.711.4 ± 4.310.9 ± 4
hsCRP (μg/dL)21 ± 6427 ± 6364 ± 124†‡
log hsCRP0.91 ± 0.421.06 ± 0.481.37 ± 0.57†‡
AST (U/L)17 ± 3.117.4 ± 4.619.2 ± 10.3
ALT (U/L)12.5 ± 4.413 ± 7.212.9 ± 11.3
GGT (U/L)14.3 ± 4.413.4 ± 3.616.4 ± 10.2
Systolic BP (mm Hg)104 ± 8106 ± 10108 ± 11
Diastolic BP (mm Hg)60 ± 761 ± 762 ± 7
  • Mean±SD AT-IR; adipose tissue-insulin resistance.

  • *P<0.05 or less by Bonferroni’s multiple comparison procedure.

  • †Low versus high.

  • ‡Normal versus high.

  • §Low versus normal.

  • ALT, alanine aminotransferase; AST, aspartate aminotransferase; BP, blood pressure; FFA, free fatty acid; GGT, γ-glutamyltranspeptidase; HDL, high-density lipoprotein; HOMA-IR, homeostasis model assessment-insulin resistance; hsCRP, high-sensitivity C reactive protein; LDL, low-density lipoprotein.